Philip Leung
@philipleungkh.bsky.social
Post-doctoral researcher @hannagroupicl.bsky.social
@imperialsandc.bsky.social | @imperialcollegeldn.bsky.social
profiles.imperial.ac.uk/p.leung
@imperialsandc.bsky.social | @imperialcollegeldn.bsky.social
profiles.imperial.ac.uk/p.leung
One of the most rewarding aspects of research @imperialmed.bsky.social is witnessing students grow into confident, curious scientists during their degrees👩🏻🔬🎓
Huge congratulations to our @imperialsandc.bsky.social students once again! Looking forward to seeing their exciting projects published soon😁
Huge congratulations to our @imperialsandc.bsky.social students once again! Looking forward to seeing their exciting projects published soon😁
Congratulations to #OurImperial students who graduated yesterday!
Particularly delighted to see BSc Medical Bioscience students that did a lab placement/project with us at the Commemoration Day! 🥳🙌🎊
@imperialsandc.bsky.social @imperialmed.bsky.social
@imperialcollegeldn.bsky.social
Particularly delighted to see BSc Medical Bioscience students that did a lab placement/project with us at the Commemoration Day! 🥳🙌🎊
@imperialsandc.bsky.social @imperialmed.bsky.social
@imperialcollegeldn.bsky.social
October 10, 2025 at 1:26 PM
One of the most rewarding aspects of research @imperialmed.bsky.social is witnessing students grow into confident, curious scientists during their degrees👩🏻🔬🎓
Huge congratulations to our @imperialsandc.bsky.social students once again! Looking forward to seeing their exciting projects published soon😁
Huge congratulations to our @imperialsandc.bsky.social students once again! Looking forward to seeing their exciting projects published soon😁
[Paper Skeet-torial]
Can VOCs be used to non-invasively monitor cancer therapy response?
In our latest pilot study in @natureportfolio.nature.com Scientific Reports, we explored the volatilomic signatures of mTOR inhibitor resistance in colorectal cancer.
🔗 nature.com/articles/s41...
1/n
Can VOCs be used to non-invasively monitor cancer therapy response?
In our latest pilot study in @natureportfolio.nature.com Scientific Reports, we explored the volatilomic signatures of mTOR inhibitor resistance in colorectal cancer.
🔗 nature.com/articles/s41...
1/n
Volatilomic response to targeted cancer therapy in vitro - Scientific Reports
Scientific Reports - Volatilomic response to targeted cancer therapy in vitro
nature.com
June 3, 2025 at 9:07 PM
[Paper Skeet-torial]
Can VOCs be used to non-invasively monitor cancer therapy response?
In our latest pilot study in @natureportfolio.nature.com Scientific Reports, we explored the volatilomic signatures of mTOR inhibitor resistance in colorectal cancer.
🔗 nature.com/articles/s41...
1/n
Can VOCs be used to non-invasively monitor cancer therapy response?
In our latest pilot study in @natureportfolio.nature.com Scientific Reports, we explored the volatilomic signatures of mTOR inhibitor resistance in colorectal cancer.
🔗 nature.com/articles/s41...
1/n
🎉Last big to-do for 2024 checked off! #PhD thesis successfully defended.
✅ Dr. Philip Leung, PhD FHEA
It’s been an enjoyable and intellectually stimulating 3-year journey working with @hannagroupicl.bsky.social and @dr--stef.bsky.social🙌
@imperialsandc.bsky.social
@imperialmed.bsky.social
✅ Dr. Philip Leung, PhD FHEA
It’s been an enjoyable and intellectually stimulating 3-year journey working with @hannagroupicl.bsky.social and @dr--stef.bsky.social🙌
@imperialsandc.bsky.social
@imperialmed.bsky.social
December 13, 2024 at 3:28 PM
🎉Last big to-do for 2024 checked off! #PhD thesis successfully defended.
✅ Dr. Philip Leung, PhD FHEA
It’s been an enjoyable and intellectually stimulating 3-year journey working with @hannagroupicl.bsky.social and @dr--stef.bsky.social🙌
@imperialsandc.bsky.social
@imperialmed.bsky.social
✅ Dr. Philip Leung, PhD FHEA
It’s been an enjoyable and intellectually stimulating 3-year journey working with @hannagroupicl.bsky.social and @dr--stef.bsky.social🙌
@imperialsandc.bsky.social
@imperialmed.bsky.social